Ovarian cancer (OC) accounts for 4% of female malignancies worldwide, and its prognosis is unfavorable. Currently available epidemiologic data suggest that non-herbal tea consumption may reduce OC risk, but these evidences are inconsistent. A comprehensive literature search for observational epidemiologic studies reporting associations between non-herbal tea consumption and OC risk was conducted in electronic databases. A random-effects model was used to synthesize effect measures in binary meta-analysis, and adjusted indirect comparison was used to compare whether there was a difference in effects between green tea (GT) and black tea (BT). Both linear and non-linear models were used to explore the dose-response relationship. Fourteen studies were included, and we obtained an inverse and significant pooled estimate in binary meta-analysis [risk ratio (RR) pool = 0.76, 95% confidence interval (CI) 0.61-0.95, P Cochran < 0.001, I 2 = 81.5%]. No publication bias was identified in binary meta-analysis. In binary meta-analysis stratified by tea types, we observed a significant association for GT (RR pool = 0.64, 95% CI 0.45-0.90, P Cochran = 0.071, I 2 = 53.6%), but not BT (RR pool = 0.85, 95% CI 0.65-1.12, P Cochran = 0.007, I 2 = 65.9%). Indirect comparison, which treated BT as the reference, showed an inverse but nonsignificant association (RR GT versus BT = 0.74, 95% CI 0.48-1.15). Both linear and non-linear models found that OC risk decreased as the consumption levels of total non-herbal tea increased. However, the dose-response relationship was stronger for GT when compared with BT. Our results suggest that non-herbal tea, especially GT, is associated with a reduced risk of OC. Future studies should explore biochemical evidence regarding the variation in chemopreventive effects between different types of non-herbal tea.
Introduction
Globally, ovarian cancer (OC) is the sixth most common cancer in women, and it has an age-adjusted incidence of 12.5 per 100 000 women (1, 2) . The incidence of OC can increase with age, and the majority of tumors are diagnosed among women older than 50 years (1). In the USA, ~20 000 women get diagnoses of OC annually (3), but OC is disproportionally deadly because of the lack of specific clinical symptoms and early detection (2) . In the USA, the Surveillance, Epidemiology, and End Results (SEER) Program indicates that the 5-year survival rate of OC is only 46.5% based on data from 2007 to 2013 (4) , and all these suggest the importance of early prevention.
Epidemiologic studies have identified some risk and protective factors of OC, but some of them can hardly be modified or implemented. For example, early menarche, late menopause and diabetes mellitus were found to be associated with an increased risk of OC (5-7); however, these factors can hardly be modified because of inherent genetic and physiological background. Hysterectomy and tubal ligation were suggested to be associated with a decreased risk of OC (1, 5, 6) , but postoperative complications (e.g. infection, hemorrhage) make this intervention approach less favorable. Medications such as non-steroidal anti-inflammatory drugs and oral contraceptives were found to reduce the incidence of OC (8, 9) , but the long-term use may introduce some other side effects. Thus, these issues raised the need to identify a more modifiable protective factor that can be easily implemented with lower cost and fewer side effects.
Tea is one of the most popular beverages worldwide (10) . Particularly, non-herbal tea such as green tea (GT) and black tea (BT) contains polyphenols (11) , which can be beneficial for human health; for example, many laboratory and populationbased studies have found a protective effect of non-herbal tea drinking on some chronic health problems (12) (13) (14) . Recently, some epidemiologic studies also found that non-herbal tea consumption was inversely associated with cancer risk. For example, a meta-analysis (15) investigating GT drinking and liver cancer reported a chemopreventive effect of GT. Guo et al. (16) synthesized data from 10 epidemiologic studies and demonstrated that a higher level of GT consumption was inversely associated with prostate cancer risk. However, current epidemiologic studies regarding the association between non-herbal tea consumption and OC risk are divergent (17) (18) (19) (20) , making the chemopreventive effects of non-herbal tea consumption controversial. Moreover, even though there could be a potential chemopreventive effect of non-herbal tea on OC, few studies investigated if such effects differed between different types of tea.
Here, we present a systematic review and meta-analysis of currently available epidemiologic studies to disentangle the relationship between non-herbal tea consumption and OC risk. Due to its low toxicity and high accessibility, non-herbal tea will be an ideal primary prevention agent for OC if its chemopreventive effects can be identified.
Methods

Search strategy
A comprehensive literature search was performed on 14 May 2017 using electronic databases. Specifically, PubMed, EMBASE, Web of Science and Scopus were used for search. Controlled vocabularies (PubMed: MeSH, EMBASE: Emtree), key words and synonyms that were related to 'ovary,' 'tea' and 'neoplasm' were included to build the search strategy (Supplementary A, available at Carcinogenesis Online). Reference lists of previous systematic reviews or original research of similar topics were checked to capture more eligible studies.
Study selection
The instruction of 'Meta-analysis of Observational Studies in Epidemiology (MOOSE)' was referred before we established the selection criteria of the study (21) . The first step of the selection process was title/abstract screening. The reviewers first read the titles and abstracts of studies from electronic databases, and studies meeting the following characteristics were selected in this step: (i) the study design was observational epidemiologic study such as cohort study and case-control study; (ii) the exposure of interest was non-herbal tea consumption, and studies reporting any tea consumption were selected in this step and received further judgment in full-text review; (iii) the outcome of interest was OC; and (iv) written in English. The second step was the full-text review process in which reviewers carefully read the whole articles to judge whether they were eligible. In full-text review, studies that had the following characteristics were included in our systematic review and meta-analysis: (i) the study reported effect measures of non-herbal tea consumption, GT consumption or BT consumption; (ii) the studies reporting risk ratio (RR), odds ratio or hazard ratio were included, but studies reporting standardized incidence ratio were not included; and (iii) the selected abstract had corresponding full text in English. Title/abstract and full text were reviewed independently by reviewers (D.Z., A.K., N.L., Y.X. and T.W.), and all discrepancies were solved by discussion within reviewers. Details of selection and exclusion are presented in a flowchart (Figure 1 ) according to the guideline of 'Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)' (22) .
Data extraction and quality assessment
After carefully reviewing the full-text articles, reviewers extracted key information and statistics of the studies. Such information included study design, locale of the study, sample size, measurement approach, types of tea, effect measures of tea consumption and adjusted confounders in multivariable models. Reviewers also evaluated methodological strengths and limitations of each study on the basis of biomedical and epidemiological knowledge. In quality assessment process, index used in 'Cochrane Handbook for Systematic Reviews of Interventions' (23) was referred when building up domains of assessment. Finally, characteristics related to representativeness, sample sufficiency, measurement accuracy and statistical rationality were considered in quality assessment. Adjusted effect measures were extracted from original studies; in addition, based on rare disease assumption (24) , odds ratios were treated as proximate measures of RRs because of the relatively low prevalence of OC among the population. These steps were also performed independently by reviewers, and discrepancies were resolved by discussion.
Synthesis of extracted data
First, a descriptive summary of study characteristics was performed qualitatively. In binary quantitative synthesis, RRs of the highest levels of tea consumption were synthesized in a random-effects model. In the random-effects model, each effect measure was weighted by the standard error of the natural logarithm of RR, which was calculated from the reported 95% confidence intervals (CIs) in the original studies (25) . Subgroup and sensitivity analyses were conducted for binary quantitative synthesis. In subgroup analysis, effect measures were synthesized based on study locales, designs, settings, tea measurement approach and tea types. Sensitivity analysis was conducted by synthesizing studies adjusting for certain covariates. Four covariates (smoking, body mass index or other anthropometric index, education and coffee consumption) were considered in sensitivity analysis, and they were selected based on a priori knowledge (26) (27) (28) . In binary quantitative synthesis, adjusted indirect comparison (AIC) (29, 30) was applied when investigating whether GT and BT had different magnitude in chemopreventive effects on OC. In indirect comparison, GT was treated as the exposure of interest, BT was treated as the reference group and non-consumers were treated as the common comparator. Particularly, we assumed that results of the observational studies in AIC were exchangeable across different sets of studies involved in the comparison (31) .
Both linear and non-linear models were used in dose-response synthesis. In dose-response models, we chose the middle point of the exposure range as the corresponding dose (e.g. tea consumption = 2-4 cups/day, corresponding dose = 3 cups/day), and the upper limit was treated as the corresponding dose if the author did not report the range (e.g. tea consumption ≥ 4 cups/day, corresponding dose = 4 cups/day). A two-stage linear dose-response model (32) and OC risk. The unit in dose-response analysis was cups per day, and studies reporting times per day were converted by assuming that subjects drank one cup of tea at each time (e.g. 2 times/day was treated as 2 cups/ day in the model). The Cochran Q statistic and I 2 value were applied to investigate statistical heterogeneity derived from quantitative synthesis. Substantial statistical heterogeneity existed if the P value derived from Cochran Q was <0.05. Moreover, we rated statistical heterogeneity across included studies by I 2 value, and I 2 > 50% suggested a substantial statistical heterogeneity. In binary quantitative synthesis, publication bias was first assessed visually by funnel plots, and a symmetrical distribution suggested a nonbiased results. Egger's test was conducted in addition to visual assessment, and P < 0.05 indicated the existence of publication bias (33) .
All statistical analyses were conducted in Stata 13.0 (StataCorp, LLP, College Station, TX).
Results
Study identification and selection
By using the search strategy, we obtained 869 records from electronic databases (PubMed: 120, EMBASE: 284, Web of Science: 242 and Scopus: 223) in total, and one article was identified by reviewing the reference lists of previous relevant studies. A total of 502 records were identified after de-duplication, and 465 of them were excluded in title/abstract screening. Reviewers read the full text of the remaining 37 articles and excluded 23 of them. The reasons for exclusion in full-text review were as follows: (i) nine articles were excluded since they did not report effect measures of non-herbal tea, (ii) six articles were excluded because of the lack of full text in English; and (iii) eight articles were excluded since they were not observational epidemiologic studies. The study identification and selection process yielded a total of 14 observational epidemiologic studies (17) (18) (19) (20) 28, (34) (35) (36) (37) (38) (39) (40) (41) (42) for this systematic review and meta-analysis.
Study characteristics and quality
Key variables extracted from studies are summarized in Table 1 . Three (18, 40, 42) of the included studies used cohort study design and nine (17, 19, 20, 28, (34) (35) (36) (37) (38) (39) 41 ) used case-control study design. These studies involved 180 833 subjects and 7500 OC cases in total. In terms of study settings, 3 studies (17, 36, 41) were clinic based, and 11 studies (18) (19) (20) 28, 34, 35, (37) (38) (39) (40) 42) were population based. The included studies were conducted in different geographical locations within a wide time period . Specifically, two were conducted in Asia (36, 41) , eight in North America (17, 18, 28, 34, 35, 37, 39, 42) , two in Europe (19, 40) and two in Australia (20, 38) . Seven of these studies (17, 35, (37) (38) (39) (40) (41) specifically reported the measures of association between a certain type of non-herbal tea and OC risk, whereas the other seven studies (18) (19) (20) 28, 34, 36, 42) just reported effect measures by treating all kinds of non-herbal tea as one category. In aspects of exposure measurement, eight studies (19, 20, 28, (34) (35) (36) 39, 41) used in-person interview approach to collect information about tea consumption, and six studies (17, 18, 37, 38, 40, 42) used selfadministered questionnaires or telephone interview to measure consumption levels. All of the studies used medical records or cancer registry data to confirm the diagnoses of OC.
The quality assessments of included studies are summarized in Supplementary B, available at Carcinogenesis Online. The included studies had some strengths in design, conduct and analysis. For instance, all of them clearly defined and described the study population in analysis and the source population if there were any. The robust measurement methods were used to collect OC-related information, which were more reliable than self-reporting or recall. However, these studies also had some limitations, which compromised their representativeness and internal validity. First, all of these studies measured tea consumption retrospectively at a single time point, which might cause misclassification in both cohort and case-control studies.
In cohort studies, tea consumption levels might change after baseline measurement. In case-control studies, recent tea consumption levels obtained from cases might only represent the levels after tumor initiation since there could be several years between tumor initiation and clinical diagnosis, and such measurement approach in case-control studies might not be able to capture the etiologically significant exposure before tumor initiation. Second, selection bias existed in several studies. Song et al. (39) selected subjects by phone numbers, and Zheng et al. (42) made the selection by driver's licenses. These could affect the distribution of socioeconomic status in the study population, which might reduce generalizability. Third, half of the included studies pooled all non-herbal tea as one kind in analysis, which introduced biomedical heterogeneity and bias in analysis, since there was a substantial difference in chemical constitution between different types of non-herbal tea (43) .
Quantitative synthesis
A total of 19 effect measures (seven for pooled non-herbal tea, seven for BT, and five for GT) were synthesized in binary metaanalysis by using a random-effects model (Figure 2 ). Among them, eight showed inverse associations without statistical significance, six showed inverse associations with statistical significance and five showed positive associations without statistical significance. The pooled measure of association between non-herbal tea consumption and OC risk was inverse with statistical significance (RR pool = 0.76, 95% CI 0.61-0.95), and substantial statistical heterogeneity was observed in the model (P Cochran < 0.001, I 2 = 81.5%). After stratification by tea types (Table 2) , we obtained an inverse and significant association for GT (RR pool = 0.64, 95% CI 0.45-0.90, P Cochran = 0.071, I 2 = 53.6%), but not BT (RR pool = 0.85, 95% CI 0.65-1.12, P Cochran = 0.007, I 2 = 65.9%). In subgroup analysis by study locale, we found that the pooled effect measure in Asian countries was inverse and significant (RR pool = 0.32, 95% CI 0.20-0.51, P Cochran = 0.059, I 2 = 64.6%), whereas pooled effect measures for Western countries were marginally significant or non-significant. In analysis by study design, we observed that the pooled measures did not change substantially between cohort studies (RR pool = 0.69, 95% CI 0.52-0.93, P Cochran = 0.527, I 2 = 0.0%) and case-control studies (RR pool = 0.77, 95% CI 0.60-0.98, P Cochran < 0.001, I 2 = 84.3%). The pooled effect measure in clinical settings was much more substantial than in population-based studies. The approach used for tea consumption measurement was associated with the magnitude of pooled effect measure, and studies using in-person interview approach yielded a more substantial effect measure. In sensitivity analysis, inverse and significant associations (Table 2) (Table 4) , we observed that pooled non-herbal tea consumption was associated with a reduced risk of OC (RR per 1 cup/day = 0.86, 95% CI 0.76-0.96). The associations turned more substantial for GT (RR per 1 cup/day = 0.69, 95% CI 0.53-0.91) but marginal for BT (RR per 1 cup/day = 0.92, 95% CI 0.83-1.02). Dose-response curves associated with linear models are presented in Supplementary E, available at Carcinogenesis Online. In non-linear models, the risk of OC decreased as the pooled non-herbal tea consumption level increased (Figure 3a) . After stratification by tea types, we observed that OC risk decreased monotonically with statistical significance as the levels of GT consumption increased till 1.7 cups/day; however, although the point estimate was still <1, the effect measure turned non-significant at consumption levels > 1.7 cups/day (Figure 3b ). For BT (Figure 3c) , the dose-response curve showed a monotone and decreasing pattern for OC risk as BT consumption levels increased; however, the effect measure was only marginally significant at a lower level of For studies treating tea consumption as an ordinal variable, only the effect measures of the highest consumption levels were included in synthesis. BMI, body mass index. In indirect comparison, green tea was treated as the exposure of interest, and black tea was treated as the reference. BMI, body mass index; NA, not applicable.
For studies treating tea consumption as an ordinal variable, only the effect measures of the highest consumption levels were included in comparison. BT consumption, and this marginal significance disappeared at levels > 2 cups/day.
Discussion
Our results suggested that non-herbal tea consumption was associated with a reduced risk of OC. On the basis of effect measures from subgroup analysis, we found that the associations did not differ significantly by study designs (cohort versus case-control) and that the pooled effect measure of Asian studies was more substantial. Although the overall binary meta-analysis showed substantial statistical heterogeneity, most of the estimates in sensitivity analysis did not change for >15%, which suggested the robustness of the association. In binary meta-analysis stratified by tea types, the effect measures suggested that GT consumption might have a stronger impact on OC risk than BT. Indirect comparison also yielded suggestive evidence demonstrating that GT might have a stronger chemopreventive effect on OC. Although none of the effect measures from indirect comparison showed statistical significance, all of them had point estimates < 1, and the directions of these effect measures were the same regardless of the restrictive selection criteria. A dose-response pattern of the inverse association between non-herbal tea and OC risk was observed in both linear and non-linear models. However, both models demonstrated that the preventive effects of GT were much more substantial, while the effects of BT were marginal. In non-linear models, the associations at higher consumption levels of GT and BT were non-significant, which might be caused by the sparse data at higher consumption levels. Although the funnel plot was asymmetrical, Egger's test did not show publication bias. Sterne et al. (44) demonstrated that the asymmetry could be associated with large random error, low study quality or small sample size in addition to publication bias. The effect measure of BT in Zhang et al. (41) located in the left bottom of the plot without having a corresponding point at the right, which could be caused by its large random error rather than publication bias.
One recently updated systematic review and meta-analysis (45) investigating the similar research question reported a significant and inverse association (RR = 0.86, 95% CI 0.76-0.96) between tea consumption and OC risk by synthesizing data from 18 epidemiologic studies. However, some methodological limitations make their results less robust. First, Zhan et al. (45) ignored the biological heterogeneity between herbal and nonherbal tea and pooled all types of tea consumption as the exposure of interest in meta-analysis, which might bias the estimate. For example, (−)-epigallocatechin-3-gallate (EGCG) is one of the main polyphenols from non-herbal tea that was found to have antitumor effects (11, 46, 47) , but substantial amount of EGCG was not commonly observed in plant strains producing herbal tea (46, 48) . Thus, combining herbal and non-herbal tea in one set of meta-analysis could obscure the true chemopreventive effects of non-herbal tea. Second, tea consumption is not a simple dichotomous factor, but Zhan et al. (45) just conducted quantitative synthesis by treating it as a binary variable and did not perform dose-response analysis, which made the dose-response relationship ambiguous. We considered such methodological issues in our meta-analysis by conducting dose-response analysis and stratification analysis by tea types (GT versus BT). The methodological elaboration can help us precisely identify the type and dosage of tea consumption that has the potential for OC prevention.
Suganuma et al. (49) found that levels of radio-labeled EGCG substantially increased in ovary tissues of female mice within the first 24 h after ingestion of 200 µl 0.05% EGCG solution; this suggests that human ovary can also be the target organ where non-herbal tea can exert antitumor effects. Several mechanisms, including apoptosis, angiogenesis and oxidative stress, may be associated with the potential chemopreventive effects of non-herbal tea on OC, and most of them involve the effects of polyphenols in GT and BT (50) . Du et al. (51) investigated the chemopreventive effects of 10 polyphenols in non-herbal tea and found that many of them like epigallocatechin (EGC) and gallocatechin gallate (GCG) had chemopreventive effects on cancer, and EGCG was the most effective one among these compounds. In vitro studies found that EGCG could induce the death of tumor cells. Laboratory evidence from Yan et al. (52) suggested that EGCG could inhibit the proliferation and induce apoptosis of OC SKOV3 cells, and the inhibitory effects on SKOV3 cells also increased in a dose-dependent pattern; in addition, Yan et al. (52) also found that EGCG could downregulate the expression of aquaporin-5, which was associated with OC growth, suggesting EGCG could inhibit tumor promotion. Second, catechins from non-herbal tea may prevent OC development by inhibiting genetic mutation; for example, by using Salmonella typhimurium TA 98 and TA 100 strains, Okuda et al. (53) found that tea catechins, epicatechin gallate (ECG) and EGCG, could inhibit the mutagenic activity of direct-acting mutagens, suggesting that non-herbal tea may prevent OC by inhibiting tumor initiation. Third, previous animal studies ( [54] [55] [56] found that EGCG could inhibit angiogenesis by suppressing the expression of vascular endothelial growth factor. Angiogenesis is important for tumor growth since vascular network plays an essential role in nutrients transportation and the removal of waste products (57) . In most conditions, solid tumors need new vessels to grow >1 mm in size (58); therefore, EGCGinduced suppression on angiogenesis can be associated with its chemopreventive effects. Fourth, oxidative stress, which features the imbalance between reactive oxygen species and antioxidant defenses (59) , has been found to be associated with the carcinogenesis process on the basis of laboratory evidence (60) (61) (62) (63) (64) (65) . For example, reactive oxygen species-mediated activation of Erk1/2 pathways can increase OC cell survival, anchorage-independent growth and motility (66) , which may contribute to OC development Only case-control studies were included in the two-stage linear dose-response model due to the limited number of available cohort studies.
The following studies were included for dose-response analysis: by facilitating tumor promotion process. EGCG is a natural antioxidant (67) , which can prevent oxidative stress-induced molecular damage such as DNA breakage based on evidence from in vitro studies (68) (69) (70) ; for example, Xu et al. (70) observed that EGCG could inhibit the formation of oxidative stress-induced DNA base (8-hydroxydeoxyguanosine) and development of lung adenomas in animal models. Thus, non-herbal tea, which is rich in EGCG, may have the chemopreventive effects on OC by preventing oxidative stress-associated pathogenesis.
Results from meta-analysis indicate that GT has a stronger chemopreventive effect than BT, and this finding is consistent with previous systematic review and meta-analyses. Specifically, four systematic review and meta-analyses (71-74) investigating tea and cancer risk (breast, prostate, lung and colorectal cancer) found that the effect measures of GT were more substantial than that of BT even though both tea types showed inverse associations. Although the underlying mechanism is not fully uncovered, such heterogeneity may be related to the difference in chemical constitution between tea types. The levels of galloylated catechins (e.g. ECG, EGCG, GCG) in GT are significantly higher than those in BT (43), for instance, Lee et al. (48) measured the total antioxidant capacity of GT and BT, and analytical results suggested that concentration of EGCG in GT was ~30% higher than in BT, indicating the stronger chemopreventive effects in GT might be related to the higher levels of galloylated catechins. However, this still cannot completely disentangle the heterogeneity since BT also contains other types of polyphenols whose level is lower in GT. Gallic acid, which has been found to have antitumor characteristics (75, 76) , was proved to exist at a higher concentration in BT when compared with GT at the same temperature (77) . Given these complexities, a comprehensive analysis of polyphenols in GT and BT is needed to compare their magnitude in prevention.
In addition, the difference in tea consumption pattern between Asian and Western countries may be associated with the result that pooled effect measure from Asian studies is much more substantial. Reports from the United Nations found that over two-thirds of non-herbal tea production in China was GT, whereas similar evidence in the USA suggested that 80% of non-herbal tea drinkers consumed BT (78, 79) . This indicates that non-herbal tea drinkers in Asia may be exposed to a higher level of galloylated catechins such as EGCG. In our meta-analysis, six effect measures from Western countries did not specify tea types, which implicitly increased the weight of BT and resulted in less substantial effect measures in synthesis.
Our study has some strengths in design and analysis. First, four large electronic databases were searched, and hand-search approach was used to obtain more eligible articles, which largely diminished the chance of missing appropriate studies. Second, our research is the first meta-analysis that used AIC and doseresponse models investigating the chemopreventive effects of GT and BT separately, which allows us to compare the effects between different types of tea and dosages. However, there are still some limitations in our study. First, we only included articles written in English, which makes it hard for us to investigate the association among subjects speaking other languages. Second, duration of tea consumption is an important factor when evaluating its chemopreventive effects in addition to frequency of drinking; however, we are unable to explore the effects of duration of consumption due to the limited data from original articles. Third, in AIC, we assumed that different studies in the same set of comparison shared a common reference group, which should be 'non-consumer'. However, Steevens et al. and Gates et al. (34, 40) used people consuming tea at a lower level as the reference group, which may introduce bias in AIC.
Our study has some health implications. OC accounts for 4% of all female malignancies in the world (80) , and the National Cancer Institute in the USA estimated that the expenditure of OC care in 2016 was 5.7 billion, which was the highest among all gynecological malignancies (81) . Thus, when compared with other primary prevention strategies, a potential chemopreventive effect of non-herbal tea consumption on OC may identify a low-cost preventive strategy. Since most consumers in Western countries may prefer drinking BT (79), which is shown to have a weaker chemopreventive effect, nutritionists and gynecologists in those areas should consider suggesting women at high risk drink more GT. Moreover, non-herbal tea is a group of popular beverages in the world, and it is an easily accessible product. These factors make it an ideal chemopreventive agent for OC prevention. On the other hand, although our study suggests non-herbal tea may have an antitumor effect, physicians should consider some side effects of excessive non-herbal tea consumption when making the recommendation. For example, a review (82) suggests high-level BT drinking can inhibit non-heme iron absorption, indicating it is more reasonable for women at high risk of iron deficiency to drink non-herbal tea intermittently.
In conclusion, our study suggests that non-herbal tea, especially GT, is associated with a reduced risk of OC, and the chemopreventive effects exist in a dose-response manner. Future studies should investigate how duration of consumption can impact the risk of OC and explore biochemical evidence regarding the variation in chemopreventive effects between different subtypes of non-herbal tea.
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